Interestingly, IL1RAPL1 expression correlates with improved prognosis in patients with mammary carcinoma (online supplemental figure S5C) and with the γδ T-cell marker ZBTB16 (online supplemental figure S5D). This evidence concerns the gene IL1RAPL1 and breast carcinoma.